The advertisement promotes TECARTUS (brexucabtagene autoleucel), highlighting its use and warning about potential severe side effects, specifically Cytokine Release Syndrome (CRS). It advises against use in certain patient populations and suggests treatment options for CRS.
Creative Information
| CID: | 68dd8df7-3bb8-48dd-9001-0f169c717e27 |
| CRID: | 89_249239 |
| Domain: | tecartus.com |
| Seat: | DInt |
| Size: | 728x90 |
| Bid: | $36.21 |
| Timestamp: | 11/18/2025, 8:35:48 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/18/2025, 10:02:23 PM | 4.71s | |
| adomain_analysis | success | 12/10/2025, 1:46:05 AM | 6.11s | |
| adomain_capture | success | 11/19/2025, 2:33:11 AM | 0.18s | |
| ad_render | success | 11/18/2025, 10:02:18 PM | 23.90s | |
| brand_mapping | success | 11/18/2025, 8:35:48 PM | 0.09s | |
Analysis Results
Ad Format: banner
Brands: TECARTUS
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 728x90 | ||||||||||||||||||||||
| Data Transferred: | 1348.09 KB | ||||||||||||||||||||||
| Render Time: | 9.02 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1348.17 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


